Deferred Tax Assets, Valuation Allowance of ABVC BIOPHARMA, INC. from 30 Sep 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ABVC BIOPHARMA, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2011 to 31 Dec 2025.
  • ABVC BIOPHARMA, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $7,356,615, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $7,356,615 +$965,979 +15% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $6,907,870 +$633,300 +10% 30 Sep 2025 10-Q/A 03 Mar 2026 2025 Q3
Q2 2025 $6,761,724 +$519,239 +8.3% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $6,584,028 +$331,246 +5.3% 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q4 2024 $6,390,636 +$659,070 +11% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $6,274,570 -$83,763 -1.3% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $6,242,485 -$103,349 -1.6% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $6,252,782 -$1,326,472 -18% 31 Mar 2024 10-Q 17 May 2024 2024 Q1
Q4 2023 $5,731,566 -$727,908 -11% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $6,358,333 +$5,709,617 +880% 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 $6,345,834 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $7,579,254 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $6,459,474 +$3,200,446 +98% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $648,716 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q4 2021 $3,259,028 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2015 $25,734 +$21,975 31 Dec 2015 10-Q 23 Feb 2016 2016 Q1
Q3 2015 $29,075 -$25,590 30 Sep 2015 10-K 27 Nov 2015 2015 FY
Q2 2015 $8,380* 30 Jun 2015 10-Q 19 Aug 2015 2015 Q3
Q1 2015 $3,885* 31 Mar 2015 10-Q 05 Jun 2015 2015 Q2
Q4 2014 $3,759* +$3,759 31 Dec 2014 10-Q 23 Feb 2016 2016 Q1
Q3 2014 $3,485* -$3,485 30 Sep 2014 10-K 27 Nov 2015 2015 FY
Q4 2013 $0 31 Dec 2013 10-Q 17 Apr 2015 2015 Q1
Q3 2013 $0 -$1,937,364 -100% 30 Sep 2013 10-K 17 Apr 2015 2014 FY
Q3 2012 $1,937,364 -$2,681,853 -58% 30 Sep 2012 10-K 16 Apr 2015 2013 FY
Q3 2011 $4,619,217 30 Sep 2011 10-K 15 Apr 2015 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.